The board of directors of AbbVie Inc. has authorized a $5B increase to AbbVie’s existing stock repurchase program. Purchases may be made from time to time at management’s discretion. The stock repurchase authorization permits shares to be repurchased in open market or private transactions, has no time limit and may be discontinued at any time.